Verastem, Inc. (VSTM)

$7.41

+0.17

(+2.35%)

Market is closed - opens 8 PM, 07 Dec 2023

Performance

  • $7.11
    $7.78
    $7.41
    downward going graph

    4.12%

    Downside

    Day's Volatility :8.68%

    Upside

    4.76%

    downward going graph
  • $3.87
    $15.18
    $7.41
    downward going graph

    47.77%

    Downside

    52 Weeks Volatility :74.51%

    Upside

    51.19%

    downward going graph

Returns

PeriodVerastem, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-24.62%
0.0%
0.0%
6 Months
-33.84%
2.2%
0.0%
1 Year
1752.5%
-4.7%
-2.1%
3 Years
227.88%
18.0%
-6.5%

Highlights

Market Capitalization
179.7M
Book Value
$3.29
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-3.89
PEG Ratio
-1.89
Wall Street Target Price
28.79
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-33.85%
Return On Equity TTM
-91.87%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
-100.0%
Gross Profit TTM
2.6M
EBITDA
-77.7M
Diluted Eps TTM
-3.89
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-3.47
EPS Estimate Next Year
-3.1
EPS Estimate Current Quarter
-0.84
EPS Estimate Next Quarter
-0.67

Analyst Recommendation

Buy
    92%Buy
    7%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Verastem, Inc.(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 288.53%

Current $7.41
Target $28.79

Technicals Summary

Sell

Neutral

Buy

Verastem, Inc. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Verastem, Inc.
Verastem, Inc.
4.96%
-33.84%
1752.5%
227.88%
66.89%
Moderna, Inc.
Moderna, Inc.
9.42%
-35.83%
-54.97%
-49.47%
333.33%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
0.6%
13.15%
9.35%
68.7%
124.16%
Novo Nordisk A/s
Novo Nordisk A/s
-4.03%
23.9%
55.84%
186.15%
330.1%
Seagen, Inc.
Seagen, Inc.
0.86%
10.81%
80.8%
20.4%
259.73%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-6.55%
8.87%
11.3%
55.67%
105.25%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Verastem, Inc.
Verastem, Inc.
NA
NA
-1.89
-3.47
-0.92
-0.34
0.0
3.29
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-12.72
-0.22
-0.07
0.0
35.32
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
23.18
23.18
1.75
42.5
0.17
0.09
0.01
234.47
Novo Nordisk A/s
Novo Nordisk A/s
41.18
41.18
4.02
2.67
0.89
0.22
0.01
20.77
Seagen, Inc.
Seagen, Inc.
NA
NA
18.53
-4.16
-0.28
-0.13
0.03
13.52
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
26.38
26.38
0.5
15.04
0.23
0.14
0.0
64.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Verastem, Inc.
Verastem, Inc.
Buy
$179.7M
66.89%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$30.4B
333.33%
24.73
-38.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$88.5B
124.16%
23.18
30.47%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$459.0B
330.1%
41.18
35.11%
Seagen, Inc.
Seagen, Inc.
Hold
$40.2B
259.73%
NA
-32.61%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$90.5B
105.25%
26.38
35.94%

Institutional Holdings

  • Viking Global Investors LP

    9.72%
  • Bvf Inc

    6.67%
  • Deerfield Management Co

    6.09%
  • Vivo Capital, LLC

    6.09%
  • Orbimed Advisors, LLC

    6.05%
  • Soleus Capital Management, L.P.

    5.33%

Corporate Announcements

  • Verastem, Inc. Earnings

    Verastem, Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com

Organization
Verastem, Inc.
Employees
57
CEO
Mr. Brian M. Stuglik BPHARM, R.Ph., RPh
Industry
Health Technology

FAQs